Article
Novartis gets FDA nod to begin making Zolgensma in North Carolina
Rating:
0.0
Views:
59
Likes:
1
Library:
1
Novartis can begin producing its spinal muscular atrophy (SMA) gene therapy, Zolgensma, at its North Carolina plant following FDA'sĀ approval for a
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value